FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
96 letters match. Newest first.
-
DrugsFirstCham Co., Ltd.
FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.
High risk -
DrugsEzriCare LLC
EzriCare distributed non-sterile Artificial Tears made by a CMO with CGMP violations, linked to a Pseudomonas outbreak.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
DrugsSudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi
FDA warns Turkish hand sanitizer maker Sudesan of CGMP violations and adulterated drugs.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA cited Intas Pharmaceuticals for CGMP violations, including manipulated visual inspection records and inadequate sterile-drug controls.
High risk -
DrugsHandock Cosmetics Co., Ltd.
FDA warns Handock Cosmetics over manufacturing quality failures and unapproved/mislabeled hand sanitizers from South Korea.
High risk -
DrugsSun Pharmaceutical Industries Ltd.
FDA warns Sun Pharmaceutical over CGMP violations in sterile injectable manufacturing at its Halol, India facility.
High risk -
DrugsCVS Health
FDA told CVS Health its unapproved Pink Eye Relief Drops are an illegal new drug made by a manufacturer with serious quality violations.
High risk -
DrugsTRP Company, Inc
FDA warns TRP Company that its homeopathic eye drops and ointments are unapproved new drugs and may be adulterated.
High risk -
DrugsWalgreens Boots Alliance, Inc.
FDA warned Walgreens over three store-brand eye drops sold as unapproved new drugs and tied to contract manufacturer manufacturing violations.
High risk -
DrugsSimilasan AG
Similasan AG's ophthalmic drugs are unapproved new drugs and violate CGMP (manufacturing quality rules), FDA says.
High risk -
DrugsGreen Pharmaceutical Co. Ltd.
FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.
High risk -
DrugsGadal Laboratories Inc.
FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.
High risk -
DrugsK. Boeun Pharmaceutical Co., Ltd.
K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.
High risk -
DrugsBaxter Healthcare Corporation
FDA warned Baxter over CGMP violations at its India plant, including inadequate endotoxin and visual inspection investigations for sterile injectables.
High risk -
DrugsChampaklal Maganlal Homeo Pharmacy Private Limited
FDA says Champaklal Maganlal Homeo Pharmacy's Bebelyn diarrhea and colic products are unapproved new drugs for infants.
High risk -
DrugsPharmedica USA, LLC
FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.
High risk -
FoodEarthLab, Inc., dba Wise Woman Herbals
FDA warned EarthLab, doing business as Wise Woman Herbals, over unapproved drug claims and supplement CGMP violations.
High risk -
DrugsPremier Nutra Pharma Inc.
FDA cited Premier Nutra Pharma, a Carlsbad, California contract maker of nasal spray drugs, for CGMP violations after microbial contamination.
High risk -
FoodSpartan Enterprises Inc. dba Watershed Wellness Center
FDA warned Spartan Enterprises/Watershed Wellness that its Dr. Bob’s Naturals supplements are unapproved drugs and are made under CGMP violations.
High risk -
FoodAspire Pharmaceuticals, Inc.
FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.
High risk -
DrugsDunagin Pharmaceuticals Inc. dba Massco Dental
Dunagin Pharmaceuticals dba Massco Dental made oral drugs with CGMP violations including shared equipment and inadequate component testing.
High risk -
DrugsAtlantic Management Resources LTD dba. Claire Ellen Products
Atlantic Management Resources (Claire Ellen Products) had CGMP violations and distributed unlisted Neuroquell Plus Cream.
Medium -
DrugsGascó Industrial Corporation
FDA cites Gascó Industrial for CGMP violations in OTC hand soap, antiseptics, and hand sanitizer, including shared equipment with industrial products.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.
High risk -
DrugsUrban Electric Power
Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.
High risk -
DrugsCentrient Pharmaceuticals India Private Limited
Centrient Pharmaceuticals India's API plant drew FDA CGMP violations, including weak records and unproven beta-lactam contamination testing.
High risk -
DrugsNatureLab Corp.
FDA warned NatureLab Corp., a Carrollton, Texas dietary supplement maker, that its products are adulterated from CGMP violations and misbranded.
Medium -
DrugsEksa Mills S.A. de C.V.
FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.
High risk -
DrugsLegacy Pharmaceutical Packaging LLC
Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.
High risk -
FoodNutritional Laboratories International, Inc. DBA Elite One Source Nutritional Services, Inc.
FDA warns Nutritional Laboratories International over CGMP violations and misbranded dietary supplement labels found after 2021 inspection.
Medium -
DrugsCangene BioPharma, LLC dba Emergent BioSolutions
FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.
High risk -
DrugsVerde Cosmetic Labs LLC
FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.
High risk -
DrugsAire-Master of America, Inc.
FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.
High risk -
DrugsColorful Products Corporation
FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.
High risk -
FoodC R Supplements, LLC
FDA warned C R Supplements that its mineral supplements were sold as unapproved new drugs and made without required quality controls.
High risk -
DrugsCetylite Industries, Inc.
FDA warned Cetylite Industries over CGMP violations at its Pennsauken, NJ facility, including unvalidated testing and inadequate OOS investigations for topical anesthetics.
High risk -
DrugsVitae Enim Vitae Scientific Inc.
FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.
High risk -
DrugsYusef Manufacturing Laboratories, LLC
FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.
High risk -
DrugsSanitor Corporation
Sanitor Corporation was cited for CGMP violations after hand sanitizer failed microbial testing and skin-bleaching drugs were sold without approval.
High risk -
DrugsGlobal Sanitizers LLC
Global Sanitizers' hand sanitizers were adulterated with methanol substitution and had serious CGMP violations.
High risk -
DrugsMatthew 7:25 Inc dba Thrive Pharmacy
FDA says Thrive Pharmacy compounded drugs without valid prescriptions and released subpotent buprenorphine troches, making them adulterated and misbranded.
High risk -
FoodBartlett Cooperative Association Bartlett Feed Mill
Bartlett Feed Mill made cattle feed with super-potent monensin; it was reported to contribute to 87 cattle deaths.
High risk -
DrugsAmerican Specialty Pharmacy, Inc. dba ASP Cares
FDA warned outsourcing facility ASP Cares about sterile compounded drugs made under insanitary conditions and with CGMP violations.
High risk -
DrugsDibar Nutricional S. de R.L. de C.V.
Dibar Nutricional's OTC drugs drew FDA CGMP violations and an import alert over missing testing.
High risk